A staging system for testicular cancer was developed at the Royal Marsden Hospital. It applies to both seminomas and nonseminomatous germ cell tumors. The Royal Marsden Hospital is in London.
Serum markers:
(1) alpha fetoprotein (AFP)
(2) beta human chorionic gonadotropin (HCG)
Clinical Extent |
Stage |
---|---|
no physical evidence of metastases |
I |
metastases to abdominal lymph nodes |
II |
metastases to supradiaphragmatic lymph nodes |
III |
metastases to extralymphatic sites |
IV |
Clinical Findings |
Stage |
---|---|
no evidence of metastases and no elevation of serum markers |
I |
elevation of serum markers but no other evidence of metastases |
IM |
metastases to abdominal lymph nodes (see below) |
II-ABC |
metastases to mediastinal lymph nodes |
III-M |
metastases to supraclavicular, cervical and/or axillary lymph nodes |
III-N |
metastases to abdominal lymph nodes (see below) |
III-OABC |
lung metastases (see below) |
IV-L1 to L3 |
metastases to liver |
IV-H+ |
metastases to brain |
IV-Br+ |
metastases to bone |
IV-Bo+ |
Abdominal Lymph Node Metastases |
Subcode |
---|---|
< 2 cm in diameter |
A |
2 - 5 cm in diameter |
B |
> 5 cm in diameter |
C |
Lung Metastases |
Subcode |
---|---|
1 - 3 metastases |
L1 |
> 3 metastases, largest <= 2 cm in diameter |
L2 |
> 3 metastases, largest > 2 cm in diameter |
L3 |
Worse prognosis is associated with:
(1) Stage IIC (and probably Stage IIIC)
(2) Stage IV L3
(3) Stage IV H+
(4) Stage IV Bo+
Purpose: To evaluate a male with a testicular cancer using the staging system developed at Royal Marsden Hospital.
Specialty: Hematology Oncology, Surgery, general, Urology
Objective: clinical diagnosis, including family history for genetics, severity, prognosis, stage, options
ICD-10: C62,